This is not the most recent version of the article. View current version (5 JUL 2013)

Intervention Protocol

Isoniazid monotherapy versus other monotherapies or combination chemotherapy for preventing active tuberculosis in HIV-negative persons

  1. Surendra K Sharma1,*,
  2. Anju Sharma2,
  3. Tamilarasu Kadhiravan1,
  4. Prathap Tharyan3

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 14 OCT 2008

DOI: 10.1002/14651858.CD007545


How to Cite

Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Isoniazid monotherapy versus other monotherapies or combination chemotherapy for preventing active tuberculosis in HIV-negative persons (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007545. DOI: 10.1002/14651858.CD007545.

Author Information

  1. 1

    All India Institute of Medical Sciences, Department of Medicine, New Delhi, India

  2. 2

    Indian Council of Medical Research, Division of Publication & Information, New Delhi, India

  3. 3

    Christian Medical College, Prof. B V Moses and Indian Council of Medical Research Advanced Centre for Research and Training in Evidence Informed Health Care, Vellore, Tamil Nadu, India

*Surendra K Sharma, Department of Medicine, All India Institute of Medical Sciences, Room 3097, Teaching Block, Ansari Nagar, New Delhi, 110029, India. surensk@gmail.com. sksharma@aims.ac.in.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

This is not the most recent version of the article. View current version (05 JUL 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the efficacy of INH monotherapy with other monotherapies or combination chemotherapy for preventing active tuberculosis in HIV-negative persons at high risk of developing active tuberculosis.